Last reviewed · How we verify
Narrative Visualization for Breast Cancer Survivors' Physical Activity
NA trial testing Narrative visualization in Breast Cancer in 40 participants. Completed in 31 March 2022.
| Lead sponsor | The University of Texas Medical Branch, Galveston |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 1 September 2018 |
| Primary completion | 30 December 2021 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across United States |
The University of Texas Medical Branch, Galveston
Adults 55 to 79, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percentage of daily workbook entries completed out of the total possible number, measured by photography of intervention materials at 12 week assessment and then assessment of each page.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 44 | ± 45 |
Mean of daily steps taken from accelerometers worn for 7 days
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 936.22 | ± 1332.46 |
| Standard Self-regulation | 913.68 | ± 1613.03 |
Mean of steps per day taken from accelerometers worn for 7 days
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | -829.37 | ± 1320.50 |
| Standard Self-regulation | -893.73 | ± 1191.96 |
Self-reported intrinsic regulation on a scale from 0 (least motivated) to 4 (most motivated) using the Behavioral Regulation in Exercise Questionnaire - 3. Reported here are results from the intrinsic regulation subscale. Higher results on the scale indicate greater intrinsic regulation.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 0.49 | ± 1.24 |
| Standard Self-regulation | 0.46 | ± 1.03 |
Self-reported integrated regulation on a scale from 0 (least motivated) to 4 (most motivated) using the Behavioral Regulation in Exercise Questionnaire - 3. Here, results from the integrated regulation subscale are reported. Higher numbers on the scale indicate greater integrated regulation.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 0.39 | ± 1.13 |
| Standard Self-regulation | 0.17 | ± 1.17 |
Self-reported fulfillment of basic psychological needs on a scale from 1 (least fulfilled) to 5 (most fulfilled) using the Basic Psychological Needs in Exercise Questionnaire. The three subscales are perceived autonomy, competence, and relatedness. Here, autonomy is reported. A higher score means greater perceived autonomy.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 0.96 | ± 1.17 |
| Standard Self-regulation | 0.50 | ± 0.79 |
Self-reported identity as an exerciser on a scale from 1 (strongly disagree) to 7 (strongly agree) as measured by the Exercise Identity Scale. The two subscales are exercise beliefs and exercise role identity. Here, exercise role identity is reported. A higher score means greater exercise role identity.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 0.73 | ± 1.42 |
| Standard Self-regulation | 0.48 | ± 0.95 |
Self-reported fulfillment of basic psychological needs on a scale from 1 (least fulfilled) to 5 (most fulfilled) using the Basic Psychological Needs in Exercise Questionnaire. The three subscales are perceived autonomy, competence, and relatedness. Here, competence is reported. A higher score means greater perceived competence.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 1.04 | ± 1.25 |
| Standard Self-regulation | 0.77 | ± 0.83 |
Self-reported fulfillment of basic psychological needs on a scale from 1 (least fulfilled) to 5 (most fulfilled) using the Basic Psychological Needs in Exercise Questionnaire. The three subscales are perceived autonomy, competence, and relatedness. Here, relatedness is reported. A higher score means greater perceived relatedness.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 0.12 | ± 1.36 |
| Standard Self-regulation | 0.41 | ± 1.94 |
Self-reported self-reflection on a scale from 1 (strongly disagree) to 5 (strongly agree) using the Self-Reflection and Insight Scale. Here, we report changes in the insight subscale, which has 8 items and a range of 5-40. For this scale, higher values indicate greater levels of insight.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 0.56 | ± 2.38 |
| Standard Self-regulation | 1.63 | ± 3.58 |
Self-reported quality of life on a scale from 0 (not at all) to 4 (very much) using the Functional Assessment of Cancer Therapy - Breast measure. Reported here is the change in total score for the entire measure (with the total ranging from 0-123). Better quality of life is indicated by a lower score.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | 4.04 | ± 8.04 |
| Standard Self-regulation | 8.92 | ± 12.13 |
Self-reported importance of family, intimate relationships, friends, work, health, and growth values domains on a scale from 0 (not at all important) to 5 (extremely important) using the Chronic Pain Values Inventory. Reported here is the change in total across all domains, which is an average of the individual items (range: 0-5). A higher score indicates stronger endorsement of importance of the valued domains.
| Group | Value | 95% CI |
|---|---|---|
| Narrative Visualization | -0.23 | ± 0.38 |
| Standard Self-regulation | 0.15 | ± 0.56 |
This study tests the feasibility and acceptability of a physical activity intervention that combines use of a wearable activity monitor with a scrapbook. Half of the participants will receive this enhanced intervention, while the other half will receive a wearable activity monitor with a standard step log.
3 peer-reviewed publications reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03612596.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing